D5-PHARMA
ActiveSummary
D5-PHARMA has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €115,485 and a net result of €26,472. Equity is shrinking by about 17% per year across the filed financial years. Its solvency ranks better than 19% of 12,686 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.2% (low).
Group and network
Connections & network
2 connected companiesThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
AGANJU CONCEPT
Shared corporate director
→
PHARMACIE SPITAELS
Shared corporate director
→